Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Cash from Investing Activities (2022 - 2024)

Abpro Holdings' (ABPO) quarterly Cash from Investing Activities came in at -$20000.0 in Q3 2024, up 33.33% on a QoQ basis from -$30000.0 in Q2 2024.

Abpro Holdings (ABPO) Cash from Investing Activities (2022 - 2024) Analysis & Trends

Abpro Holdings (ABPO) has 3 years of Cash from Investing Activities data on file, last reported at -$20000.0 in Q3 2024.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$20000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $29.5 million (down 89.43% YoY) and the FY2023 annual result came in at $278.4 million, up 191.09% from the prior year.
  • Cash from Investing Activities improved to -$20000.0 in Q3 2024, from -$30000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $278.6 million in Q2 2023 to a low of -$306.0 million in Q1 2022.
  • A 3-year average of $344890.7 and a median of -$20000.0 in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 148.26% — and 2024, when it tumbled 100.01%.
  • Tracing ABPO's Cash from Investing Activities over 3 years: stood at $331516.0 in 2022, then plunged by 148.26% to -$160000.0 in 2023, then surged by 87.5% to -$20000.0 in 2024.
  • The last three Cash from Investing Activities figures came in at -$20000.0 (Q3 2024), -$30000.0 (Q2 2024), and $29.7 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -20,000.00
Sep 30, 2024 -20,000.00
Jun 30, 2024 -30,000.00
Jun 30, 2024 -30,000.00
Mar 31, 2024 29.69 Mn
Mar 31, 2024 29.69 Mn
Dec 31, 2023 -160,000.00
Dec 31, 2023 -160,000.00
Jun 30, 2023 278.60 Mn
Jun 30, 2023 278.60 Mn
Dec 31, 2022 331,516.00
Dec 31, 2022 331,516.00
Mar 31, 2022 -306.00 Mn
Mar 31, 2022 -306.00 Mn